Have an Emergency?

For urgent assistance, please contact emergency response services.

Call: 911

Product Questions?

Questions, comments or concerns about Rising Pharma products? Contact one of our trusted professionals today.

Call (800) 521-5340

Compare Products

Compares to the labeled active ingredients in Reference Brand. The trademark or tradename referenced is NOT registered, owned or licensed by Rising Pharma Holdings, Inc. or its affiliates.

Zolmitriptan IR Tablets Zolmitriptan IR Tablets

Zolmitriptan IR Tablets

Compare to: Zomig® Tablets*
Strength: 2.5mg | 5mg
* Zomig® is a registered trademark of IPR Pharmaceuticals, Inc.
This information has been designed as a quick reference. It is intended as a reference source only and not for prescribing or dispensing product. The appropriate approved prescribing information should be consulted. Images viewed herein may appear different than they do when viewing them live because of computer and/or photographic distortion. In addition, over time, some images and information for a particular product may change. For the most up-to-date product information, please contact your pharmacist or physician.

Zolmitriptan is indicated for the acute treatment of migraine with or without aura in adults

Limitations of Use

  • Only use zolmitriptan if a clear diagnosis of migraine has been established. If a patient has no response to zolmitriptan treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan is administered to treat any subsequent attacks.
  • Zolmitriptan is not indicated for the prevention of migraine attacks.
  • Safety and effectiveness of zolmitriptan have not been established for cluster headache.